Acumen Pharmaceuticals Inc

Acumen Pharmaceuticals Inc is a standout in the biopharmaceutical sector, focusing primarily on the research, development and commercialisation of transformative treatments for serious neurodegenerative diseases. The company conducts its groundbreaking operations globally and has an extensive impact on the healthcare landscape. Acumen Pharmaceuticals Inc excels in advancing promising therapeutic candidates for severe diseases such as Alzheimer's. While operating independently, the company is renowned for its key product candidate, Aducanumab, which has the potential to stabilise and improve cognitive function in Alzheimer’s patients. Stay up to date on the share price of ABOS by adding it to your eToro watchlist.